Novelties in Antibiotic Therapy, Microbial Resistance and Best Stewardship Practices

Dear Colleagues,

The world of microorganisms continues to bedazzle us with its outstanding ability to adapt and evade our defense of discovered drugs. Unfortunately, this evolution poses a paramount burden on health care systems around the globe. Treatment of patients infected with resistant microorganisms is associated with high morbidity and mortality along with the consumption of sizable financial resources. Research provides insights into several aspects such as new drug discovery, the repurposing of available antimicrobials, tracking microbial resistance, optimizing clinical outcomes and devising antimicrobial stewardship policies and procedures. These strides have the overall aim of preserving our ability to treat infectious diseases and halting the reversion to the pre-antibiotic era. In this Special Issue, we welcome submissions from all over the world that would shed light on developing new antimicrobials, addressing gaps in antimicrobial therapy and refining antimicrobial stewardship practices.

Dr. Islam M. Ghazi
Dr. Wasim S. El Nekidy
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• Microbial Resistance
• Antimicrobial Stewardship
• Antibiotics
• Animal Models
• In Vitro Models
• Pharmacokinetics/Pharmacodynamics